[1]
Eandi, M. et al. 2013. Costs of treatment of haemophilia A in Italy: comparison of the use of plasma-derived and recombinant FVIII using a discrete event simulation (DES) model. Farmeconomia. Health economics and therapeutic pathways. 14, 2 (Apr. 2013), 51–74. DOI:https://doi.org/10.7175/fe.v14i2.651.